CorMedix EVP, General Counsel and Corporate Secretary Phoebe Mounts to depart Dec 31, 2023

CorMedix Inc.

Mutual separation approved Dec 12, 2023; Mounts ceases as General Counsel and Corporate Secretary immediately, remains EVP through Dec 31.
Termination classified as without cause under Employment Agreement; severance contingent on signing release, cooperation, return of property, and compliance with covenants.
No replacement named; Mounts will assist with transition until Termination Date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Phoebe Mounts

Executive Vice President, General Counsel and Corporate Secretary

CRMD · CorMedix Inc.

Effective: 2023-12-31
Filed: December 15, 2023, 6:59 PM ET

On December 12, 2023, upon mutual agreement between CorMedix Inc. (the “Company”) and Phoebe Mounts, Ph.D., Esq., the Company’s Executive Vice President, General Counsel and Corporate Secretary, the Board of Directors of the Company (the “Board”) approved the separation of employment of Dr. Mounts, effective December 31, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Phoebe Mounts departed as Executive Vice President, General Counsel and Corporate Secretary at CorMedix Inc..

Action: separated
Role: Executive Vice President, General Counsel and Corporate Secretary

Exact text from the filing

On December 12, 2023, upon mutual agreement between CorMedix Inc. (the “Company”) and Phoebe Mounts, Ph.D., Esq., the Company’s Executive Vice President, General Counsel and Corporate Secretary, the Board of Directors of the Company (the “Board”) approved the separation of employment of Dr. Mounts, effective December 31, 2023

View on SEC.gov

CorMedix Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-095909

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.